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• Dynamic& labeling& patterns& combined& with& metabolite& levels& can& quantify&some&fluxes&
• Analysis& of&multiple&metabolites& and& various& tracers& enhances& information&output&&
" "
Abstract"&Measuring& intracellular& metabolism& has& increasingly& led& to& important& insights& in&biomedical& research.& 13C& tracer& analysis,& although& less& informationZrich& than&quantitative&13C&flux&analysis&that&requires&computational&data&integration,&has&been&established& as& a& timeZefficient& method& to& unravel& relative& pathway& activities,&qualitative&changes&in&pathway&contributions,&and&nutrient&contributions.&Here,&we&review&selected&key&issues&in&interpreting&13C&metabolite&labeling&patterns,&with&the&goal&of&drawing&accurate&conclusions&from&steady&state&and&dynamic&stable&isotopic&tracer&experiments.&&
Introduction"&Investigating& cellular& metabolism& has& a& longZstanding& history& in& various& research&areas& such& as& biochemistry,& biotechnology& and& cellular& physiology.& A& widely&applicable& toolbox& to& quantitatively& measure& intracellular& metabolism& has& been&developed& in& the& context& of& biochemical& engineering& [1].& In& light& of& the& emerging&realization&that&altered&cellular&metabolism&contributes&to&many&diseases&including&cancer,&metabolic& syndromes,& and& neurodegenerative& disorders,& these& approaches&are&being&increasingly&applied&to&address&biomedical&research&questions&[2Z9].&&Cellular&metabolism& can& be& characterized& by&many& parameters& including& nutrient&uptake&and&metabolite& secretion& rates,& intracellular&metabolite& levels,& intracellular&metabolic& rates& (fluxes),& nutrient& contributions& to& metabolite& and&macromolecule&synthesis,&and&pathway&activities&[2,3,9Z12].&&Metabolomics,&which&provides&absolute&or&relative&intraZ&or&extracellular&metabolite&levels,& is& a& broad& and& sensitive& method& to& detect& differences& in& metabolic& states&between& conditions& [13Z16].& Changes& in& intracellular&metabolite& levels& indicate& an&altered&activity&of&the&connected&consuming&or&producing&reactions&(e.g.&enzymatic,&nonZenzymatic,&or&transport&reactions)&[17Z21].&However,&concentration&changes&do&not&readily&allow&conclusions&on&metabolic&rates&(fluxes),&or&the&direction&of&the&flux&changes,& since& an& increase& in& metabolite& concentration& can& both& be& indicative& of&increased&activity&of&metabolite&producing&enzymes,&but& also&decreased&activity&of&metabolite&consuming&enzymes.&&In&combination&with&growth&rates&(which&provide&global& information&on&metabolic&fluxes& to& biomass& production),& metabolite& uptake/secretion& rates& provide& a&macroscopic& picture& of& overall& metabolism.& For& instance,& measuring& the& rate& of&glucose& depletion& from& the& media& reports& the& rate& of& glucose& used& by& cells& in& a&culture& system.& However,& these& data& alone& are& insufficient& to& reveal& intracellular&fluxes&throughout&the&different&metabolic&pathways.&&To& examine& intracellular& fluxes& (metabolite& amount& converted/cell/time),& heavy&isotope&(most&frequently&13C)&labeled&nutrients&(tracers)&are&commonly&utilized&[22Z29].& In& formal& 13C& flux& analysis,& labeling& patterns& in& intracellular& metabolites&resulting& from& metabolizing& a& 13C& labeled& nutrient,& cellular& uptake& and& secretion&rates,& and& prior& knowledge& of& the& biochemical& reaction& network& are& combined& to&computationally& estimate& metabolic& fluxes& [11,30Z34].& In& practice,& resolving&
metabolic&fluxes&from&measured&data&can&be&time&and&dataZintensive.&In&many&cases,&however,& direct& interpretation& of& 13C& labeling& patterns& (without& formal& 13C& flux&analysis)& is& sufficient& to& provide& information& on& relative& pathway& activities,&qualitative&changes& in&pathway&contributions&via&alternative&metabolic& routes,&and&nutrient& contribution& to& the& production& of& different& metabolites.&We& refer& to& this&direct&interpretation&of&13C&labeling&patterns&as&13C&tracer&analysis.&Here,&we&discuss&selected& important& aspects& to& consider& when& performing& 13C& tracer& analysis& to&ensure& correct& data& interpretation& and& to& increase& the& insight& obtained& by& stable&isotopic&tracer&experiments.&&
Metabolic"steady"state"versus"isotopic"steady"state"&Metabolic& steady& state& requires& that& both,& intracellular& metabolite& levels& and&intracellular&metabolic&fluxes&of&a&cell&or&a&cell&population&are&constant&(Figure&1a)&[35].&Controlled&culture&systems&that&ensure&metabolic&steady&state&are&continuous&cultures&(known&as&chemostats),&where&cell&number&and&nutrient&concentrations&are&maintained&constant&throughout&the&experiment&[36].&More&commonly,&experiments&are&performed&at&pseudoZsteady&state,&where&changes&in&metabolite&concentrations&and&fluxes&are&minimal&on&the&timescale&over&which&the&measurement&is&being&made.&In& adherent&mammalian& cell& culture,&perfusion&bioreactors& and&nutrostats& [37,38],&where& nutrient& concentrations& but& not& cell& number& are& constant& over& time,& are&closest& to&a&chemostat.& In&conventional&monolayer&culture,& the&exponential&growth&phase&is&often&assumed&to&reflect&metabolic&pseudoZsteady&state,&because&cells&in&the&culture&steadily&divide&at& their&maximal&condition&specific&rate,&given& that&nutrient&supply& does& not& become& limiting& [39].& So& long& as& biological& changes& (e.g.&differentiation)& occur& slowly& relative& to& the& timescale& of& metabolic& measurement,&nonZproliferating&cells&are&generally&also&in&metabolic&pseudoZsteady&state.&This&can&be&verified&by&time&resolved&measurements&of&metabolic&parameters&of&interest&[40].&In&case&the&biological&system&is&not&in&metabolic&pseudoZsteady&state,&e.g.& following&acute&signaling&events&or&nutrient&modulations,&tracer&experiments&can&still&provide&qualitative& and& quantitative& information& on& metabolic& pathway& fluxes,& but&interpretation&of&nonZsteady&state&data&require&different&approaches&[30,41Z43]&than&the&here&discussed&13C&tracer&analysis&at&metabolic&pseudoZsteady&state.&&While& metabolic& steady& state& addresses& the& state& of& metabolism,& isotopic& steady&state&characterizes&the&enrichment&of&a&stable&isotopic&tracer&in&metabolites.&When&a&13C& labeled& substrate& is& added&and& subsequently&metabolized,& the&metabolites&will&become& with& time& increasingly& enriched& for& 13C& until& the& point& where& the& 13C&enrichment& is& stable& over& time& (Figure& 1b).& From& a& practical& perspective,& isotopic&steady&state&is&reached&when&13C&enrichment&into&a&given&metabolite& is&stable&over&time& relative& to& experimental& error& and/or& the& desired& measurement& accuracy.&These& enrichment& dynamics& differ& depending& on& the& analyzed&metabolite& and& the&tracer&employed,&since&the&time&required&to&reach&isotopic&steady&state&depends&on&both&the&fluxes&(i.e.&rate&of&conversion)&from&the&nutrient&to&that&metabolite,&and&the&pool& sizes& of& that&metabolite& and& all& intermediate&metabolites.& For& example,& upon&labeling&with&13CZglucose,& isotopic&steady&state& in&glycolytic& intermediates&typically&
occurs& within& minutes,& whereas& for& TCA& cycle& intermediates& it& may& take& several&hours.& For& many& amino& acids& that& are& both& produced& by& the& cell& and& are&supplemented&in&the&media&isotopic&steady&state&may&never&be&achieved&in&standard&monolayer& culture,& due& to& constant& and& rapid& exchange& between& the& intracellular&and&the&extracellular&amino&acid&pools.&In&such&a&situation,&qualitative&tracer&analysis&can& easily& be& misleading,& and& quantitative,& formal& approaches& are& required& (e.g.&[44]).&&&Key&aspects:&
• Proper& interpretation& of& labeling& data& depends& on& prior& assessment& of&whether&the&system&is&at&metabolic&pseudoZsteady&state.&If&so,&interpretation&of&tracer&data&is&most&simple&if&labeling&is&allowed&to&proceed&also&to&isotopic&steadyZstate&&
• The& time& to& reach& isotopic& steady& state& depends& both& on& the& tracer& being&employed&and&the&metabolites&being&analyzed.&&
• Many& amino& acids& are& freely& exchanged& between& intracellular& and&extracellular&pools.&This& can&prevent& labeling& from&reaching& isotopic& steady&state&and&any& intracellular&metabolite&pool& that& is& in& rapid&exchange&with&a&larger&extracellular&pool&is&subject&to&this&complication.&&&
Labeling"patterns""&The&term&‘labeling&pattern’&refers&to&a&mass&distribution&vector&(MDV)&(they&are&also&frequently&called&mass&isotopomer&distribution&(MID)&vectors)&(Figure&1c).&The&shift&in&mass&of&a&metabolite&occurs&due&to&the&incorporation&of&isotopes.&Metabolites&that&only& differ& in& the& isotope& composition& are& isotopologues& (they& are& frequently& also&called& mass& isotopomers).& MDVs& describe& the& fractional& abundance& of& each&isotopologue&normalized&to&the&sum&of&all&possible&isotopologues.&A&metabolite&with&
n& carbon& atoms& can&have&0& to&n& of& its& carbon& atoms& labeled&with& 13C,& resulting& in&isotopologues&that&increase&in&mass&(M)&from&M+0&(all&carbons&unlabeled&e.g.&12C)&to&M+n& (all& carbons& labeled& e.g.& 13C).& Hence,& the& MDV& represents& the& relative&abundances&of&M+0&to&M+n&isotopologues&for&one&particular&metabolite&(Figure&1c).&Consequently,&the&sum&of&all&fractions&from&M+0&to&M+n& is&100%&or&1.&Note&that&in&respect& to& 13C& each& isotopologue& has& !! &isotopomers& (same& isotope& composition&but& different& position& of& the& isotope& within& the& metabolite),& when& n& denotes& the&number&of&carbons&in&a&metabolite&and&k&the&number&of&carbons&that&are&13C&(Figure&1c).& Isotopomers& can&only&be& resolved&using&a&detection&method& that& can&assign&a&specific& position& to& a& 13C& within& a& molecule& (e.g.& nuclear& magnetic& resonance&spectroscopy& [45],& mass& spectrometry& analysis& of& multiple& fragments& [46]& or& in&specific& cases& tandem& mass& spectrometry& [47,48]).& While& information& on& the&position&of&a&the&13C&label&can&increase&the&information&content&of&labeling&data,&the&MDV&is& typically&sufficient& to&draw&conclusions&on&nutrient&contributions,&and&also&often& regarding& pathway& activities.& Notably,& while& we& will& discuss& 13C& tracer&
analysis,& the& aboveZdescribed& MDVs& can& be& also& applied& to' other& stable& isotopes&including'15N&and&2H.&&To& apply& MDVs& to& assess& nutrient& contributions& and& pathway& activities,& it& is&important& to& first& correct& for& the&presence&of& naturally& occurring& isotopes,&e.g,& 13C&(1.07%&natural& abundance& (na)),& 15N& (0.368%&na),& 2H& (0.0115%&na),& 17O& (0.038%&na),&18O&(0.205%&na),&29Si&(4.6832%&na),&or&30Si&(3.0872%&na)&[49Z51].&For&example,&glutamate&and&αZketoglutarate,&which&are&normally&in&complete&exchange&and&share&the&same&carbon&backbone,&should&accordingly&have&matching&MDVs.&Yet,&since&they&differ& in& their& molecular& formula,& uncorrected& MDVs& of& glutamate& and& αZketoglutarate&will&not&match&because&of&the&natural&occurring&isotopes&in&N,&H,&and&O.& For& analytical& methods& that& require& metabolite& derivatization& to& enable&chromatographic& separation& (e.g.& gas& chromatography& Z& mass& spectrometry),& the&chemical&modification& adds& additional& C,& H,& N,& O,& and& Si& atoms& to& the&metabolites&[22,52].& Hence,& the& natural& labeling& of& all& atoms& in& the& metabolite& and& the&derivatization& agent& needs& to& be& taken& into& account& when& performing& data&correction.&For&analysis&of&underivatized&metabolites&(e.g.&by&liquid&chromatography&Z&mass&spectrometry),&naturally&occurring&13C&has&a&much&greater&effect&than&other&natural&isotopes,&and&it&is&minimally&imperative&to&correct&for&it.&&A&general&applicable&correction&matrix&can&be&formulated&based&on&equation&(1).&&& !!!!!!…!!…!!!!
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&Here,& the& vector& I& denotes& the& fractional& abundances& of& the&measured&metabolite&ions.&M&represents&the&MDV&corrected&for&naturally&occurring&isotopes.&n&denotes&the&number& of& carbon& atoms& that& are& present& in& the& analyzed&metabolite& ion& and& are&subject&to&isotope&labeling.&u&denotes&additional&measured&ion&abundances&beyond&n&originating&from&natural&isotopes&in&the&metabolite&or&the&derivatization.&L&denotes&the&correction&matrix&and&the&columns&!!! &denote&the&theoretical&natural&MDV&when&
k& (0& to&n)&carbons&are&13C.&The&correction&matrix&L& can&be&calculated&based&on& the&sum& formula& of& the& metabolite& ion& under& consideration& of& natural& isotope&abundances&[49,53,54].&To&solve&the&linear&equation&system&at&least&n+1&abundances&have&to&be&measured.&If&more&than&n+1&abundances&are&considered,&this&results&in&an&overdetermined& system& and& provides& a& more& robust& solution.& Tools& for& quickly&converting&raw&into&corrected&MDVs&are&available&[55,56].&&When& using& analytical& approaches& involving& selected& ion& monitoring& (SIM)& or&selected&reaction&monitoring&(SRM)&mass&spectrometry,& it& is& important&to&consider&upfront&the&potential&role&of&naturally&occurring&isotopes&when&setting&the&selected&
mass& range& [50].& In& cases& involving& derivatization& with& SiZcontaining& reagents,&inclusion& of& these& higher& mass& ranges& may& be& important& and& the& required& mass&range&can&be&estimated&based&on&multinomial&expansion&(typically&a&shift&of&up&to&4&amu&beyond&the&mass&of&the&fully&labeled&metabolite&should&be&considered).&&&Comparison& between& labeled& and& unlabeled& samples& is& sufficient& to& determine&whether&an&observed&mass&shift&truly&reflects&labeling&(as&opposed&to&merely&natural&isotope& abundance).& It& is& not& appropriate,& however,& to& subtract& the& MDV& of& an&unlabeled& sample& from& the& labeled& sample.&Typically,& the&main&natural& abundance&peak& in& the& unlabeled& sample& will& be& M+1,& whereas& in& labeled& samples& natural&abundance&results&in&peaks&at&higher&masses.&&The& natural& occurring& isotopes& can& be& also& used& to& validate& the& applied& mass&spectrometry&method& for& its& accuracy& to&measure& isotopologue& distributions& [22].&Specifically,& metabolites& can& be& extracted& from& cells& fed& with& naturally& labeled&nutrients& (commonly& referred& to& as& unlabeled& nutrients)& and& consequently& the&measured& MDV& of& these& metabolites& should& accurately& (<&±1.5%)& reflect& the&theoretical& distribution& of& natural& occurring& isotopes.& With& this& validation& the&applied&mass&spectrometry&method&can&be& improved&or&metabolites& for&which& the&isotopologue& distribution& is& measured& with& poor& accuracy& can& be& excludes.& It& is&important&to&be&aware&of&the&extent&of&error&in&MDV&measurements&and&to&interpret&resulting& labeling& data& accordingly.& Random& error& in& MDV& measurement& is& often&significant&for&metabolites&that&are&low&abundance&(i.e.&measurement&signal&close&to&noise).& Systematic& error& in& MDV& measurement& is& more& serious& and& can& reflect&metabolite&misannotations&or&overlaps&of&the&measured&metabolite& ions&with&same&mass& ions& from& sample& matrix& compounds.& In& case& the& accuracy& to& measure&isotopologue& distributions& is& validated,& data& variability& can& be& a& subject& of& the&experimental& procedure& (e.g.& inadequate&metabolism& quenching)& or& the& biological&system&(e.g.&rapid&metabolic&shifts&or&a&continuous&metabolic&drift).&&Key&aspects:&
• Correction&for&natural&abundance&facilitates&proper&interpretation&of&labeling&data.&
• Subtracting& the& measured& MDV& of& an& unlabeled& metabolite& from& the&measured&MDV&of&the&labeled&metabolite&is&not&a&valid&method&to&correct&for&natural&abundance.&




Eukaryotic&cells&have&organelles&such&as&mitochondria&and&peroxisomes,&and&these&organelles&result&in&intracellular&compartmentalization&of&metabolites&and&metabolic&reactions.&Many&metabolites&are&present&in&multiple&intracellular&compartments&and&even& spatial& distribution&within& a& compartment&might& occur.& This& adds& a& layer& of&complexity& to& understanding& metabolism.& Only& the& average& labeling& pattern& and&metabolite&levels&from&all&compartments&within&a&cell&can&be&measured&using&most&current&techniques&(Figure&1d)&[57,58].&&Depending&on&the&metabolite&of&interest,&compartmentZspecific&labeling&patterns&in&some& cases& can& be& inferred& from& labeling& of& metabolites& that& are& produced&exclusively&in&one&compartment&(Figure&1d).&For&example,&pyruvate&is&found&both&in&the&cytosol&and&in&the&mitochondria.&Lactate&and&alanine&are&both&directly&produced&from& pyruvate.& Lactate& dehydrogenase,& the& enzyme&which& interconverts& pyruvate&and&lactate,&is&a&strictly&cytosolic&enzyme&[59],&an&assumption&in&agreement&with&the&observation&that&the&deletion&of&the&mitochondrial&pyruvate&carrier&does&not&affect&lactate&production&[60,61].&The&finding&that&mitochondrial&pyruvate&carrier&deletion&drastically& affects& alanine& production& [60,61]& supports& that& alanine& is& produced&extensively&from&mitochondrial&pyruvate&[62].&Thus,&under&experimental&conditions&in&which&neither&exogenous&alanine&nor&lactate&is&available&to&cells,& lactate&labeling&likely& reflects& the& labeling& pattern& of& cytosolic& pyruvate,& while& alanine& labeling&better& reflects& the& labeling& pattern& of& mitochondrial& pyruvate.& Additionally,&engineered&compartmentZspecific&production&of&metabolites&in&cells&can&also&be&used&to&provide&compartment&specific&information.&For&example,&labeling&of&NADPH&in&the&mitochondria& and& the& cytosol& was& determined& by& compartmentalized& transfer& of&deuterium&to&the&metabolite&2Zhydroxyglutarate&(2ZHG)&[63].&Specifically,& transient&expression&of&either&mutant&isocitrate&dehydrogenase&1&or&2&results&in&compartment&specific& production& of& 2ZHG& that& utilizes& NADPH& available& in& that& location.& This&approach,& and& a& similar& approach& but& without& engineered& compartment& specific&production& of& 2ZHG& was& used& to& infer& compartmentalized& serine& –& glycine&interconversion&[63,64].&&&Key&aspects:&
• In& most& cases& cell& average& labeling& patterns& are& measured.& Because& many&metabolites&are&present&in&more&than&one&subcellular&compartment,&this&can&affect&the&extent&and&pattern&of&the&metabolite&labeling&observed.&&
Steady"state"labeling"
"MDVs& describe& the& relative& fractions& of& isotopologues& within& a& metabolite.& At&isotopic&steady&state,&and&in&the&absence&of&compartmentZspecific&labeling&patterns,&MDVs& are& independent& of& metabolite& levels.& Therefore,& metabolites& that& are& in&complete&exchange&such&as&glutamate&and&αZketoglutarate&have&identical&MDVs&even&though& their& intracellular& levels& are& very& different& [65Z67]& (Figure& 2a).&Consequently,&any&further&analysis&of&relative&pathway&activities,&qualitative&changes&in&pathway&contributions,&or&nutrient& contributions&based&on& isotopic& steady&state&labeling& data& only& requires& MDVs& and& is& independent& of& the& metabolite& levels.&
Notably,& this& simplifying& assumption& breaks& down& when& compartmentation& is&significant& and& results& in& compartmentZspecific& labeling& patterns& (see& section&above).&&
Nutrient(contribution(To& determine&which& fraction& of& a&metabolite’s& carbon& is& produced& from& a& certain&nutrient&the&fractional&contribution&(FC)&using&the&fully&13CZlabeled&nutrient&can&be&calculated& based& on& equation& (2).& Using& positionally& labeled& nutrients& for& this&analysis& is& not& advised& because& positionally& labeled& tracers& will& not& only& reflect&changes&in&the&FC&but&also&differential&pathway&usage.&For&example,&the&FCfrom&glucose&in& pyruvate& calculated& from& a& 1Z13C1Zglucose& tracer& can& be& altered& between&conditions&because&of&a&reduction&in&the&fraction&of&pyruvate&produced&from&glucose&or& because& the& forward& flux& through& the& oxidative& and& nonZoxidative& pentose&phosphate& pathway& is& increased,& leading& to& the& incorporation& of& the& 13C& labeled&carbon&into&CO2.&&&!" = ! !!∙! !!!!!!!∙! !!!!!! & (2)&&Here&n&is&the&number&of&C&atoms&in&the&metabolite,&i&denotes&the&isotopologues,&and&
m& the& abundance& of& an& isotopologue.& Alternatively,& FC& can& be& directly& calculated&from&the&MDV&by&equation&(3),&which&takes&advantage&of&the&fact&that&the&sum&of&all&fractions&from&M+0&to&M+n&is&already&normalized&to&1.&&&!" = ! !!∙!!!!!!!! &(3)&&Here&s&is&the&relative&fraction&of&the&isotopologues.&&If&only&two&carbon&sources&(e.g.&glucose&and&glutamine)&contribute&to&the&formation&of&a&metabolite,& the&sum&of&FCfrom&glutamine&and&FCfrom&glucose&will&be&100%&or&1& for&this&metabolite& (Figure& 2b).& Thus,& the& relative& contributions& of& carbon& sources& to& a&metabolite&can&be&determined&from&FCs.&As&an&example,&this&approach&was&applied&to&reveal&a&switch&from&glucose&to&glutamineZderived&tricarboxylic&acid&(TCA)&cycle&metabolites&during&metformin&treatment&[68].&For&any&metabolite&that&is&subject&to&a&carboxylation& reaction& the& FC& values& will& be& reduced& due& to& incorporation& of&unlabeled&CO2& [69].&Similarly&any&other& incorporation&of&unlabeled&carbon&sources&will&also&lead&to&a&reduced&FC.&For&example&a&low&FC&of&fatty&acids&from&13C6Zglucose&and& 13C5Zglutamine& in& hypoxia& was& recently& used& to& reveal& a& contribution& from&serum&acetate&to&fatty&acid&synthesis&[70].&&Also&isotope&impurity&of&the&tracer&will&reduce&FC&values.&Yet,&for&standard&quality&of&tracers& (e.g.& 1%& for& 13C6Zglucose),& the& reduction& of& FC& values& based& on& isotope&impurity& is& marginal.& For& example,& although& in& 13C6Zglucose& with& 1%& isotope&impurity&only&94%&of&the&glucose&molecules&carry&at&each&carbon&position&a&13C,&the&FC&for&this&13C6Zglucose&is&0.99.&Thus,&normalizing&to&the&FC&of&the&tracer&has&in&this&
case&little&effect.&However,&for&tracers&with&higher&isotope&impurity&a&normalization&to&the&FC&of&the&tracer&can&be&useful.&&&Nutrient& contribution& indirectly& provides& some& information& on& flux:& it& reveals& the&fraction&of&the&metabolite&being&formed&by&the&sum&of&all&pathways&leading&from&the&labeled& nutrient& to& the& metabolite.& It& does& not& reveal& the& activity& of& specific&pathways,&nor&absolute& fluxes.&For&example,& two&metabolites&can&have& identical&FC&although&the&net&flux&(Figure&2c)&of&the&labeled&nutrient&to&one&of&the&metabolites&is&much& smaller& than& to& the& other,& but& between& both& metabolites& exists& a& rapid&exchange&flux.&Thus,&rapid&exchange&fluxes&(Figure&2c)&can&readily&label&metabolites&although&the&net&flux&to&the&metabolite&might&be&marginal.&&Key&aspects:&
• If&the&sum&of&the&labeled&nutrient&contributions&to&a&metabolite&do&not&sum&up&to&100%&or&1,&and& the& labeling& in& the&metabolite& is& in& isotopic& steady&state,&there& are& additional& sources& that& contribute& to& the& production& of& that&metabolite.&
• In& general,& nutrient& contributions& alone& do& not& reveal& specific& or& absolute&fluxes.&
• Exchange&fluxes&can&lead&to&labeled&metabolites&although&the&net&flux&to&the&metabolites&is&marginal.&&
Pathway(activity((Specific& isotopologues&do&not&provide&per'se& information&on&absolute&fluxes,&rather&they& allow& conclusions& on& relative& pathway& activities& and& qualitative& changes& in&pathway& contributions& to& the& production& of& a& certain& metabolite.& Thereby,&isotopologue&patterns&can&indicate&the&activity&of&alternative&metabolic&routes.&&
Relative'pathway'activity&Relative&pathway&activities&can&be&inferred&from&a&ratio&between&two&alternative&and&converging&pathways.&A&13C&labeled&tracer&can&be&fed&to&the&cells,&which&is&designed&to& result& in& different& labeling& patterns&when& converted& through& either& of& the& two&alternative&metabolic&pathways.&Calculating&a&split&ratio&of&the&activity&between&two&alternative& and& converging& pathways& requires& that& the& labeling& patterns& of& the&metabolites&are&valid&surrogates&of&the&two&pathways,&and&that&a&converged&pathway&metabolite&can&be&measured&[50].&Consequently,& the&sum&of& the&relative&activity&of&both& alternative& and& converging& pathways& is& 100%& or& 1.& In& those& cases& where&additional& information&can&provide& the& forward& flux& for&one&of& the&pathways,& then&the&forward&flux&of&the&other&pathway&can&be&calculated&based&on&the&split&ratio.&&For&example,&the&pentose&phosphate&pathway&has&both&oxidative&and&nonZoxidative&branches& that& connect& to& glycolysis& at& different& locations& [71].& Under& some&conditions,&pentoses&produced&via&the&oxidative&pathway&can&reZenter&glycolysis&via&the& nonZoxidative& pathway,& providing& two& routes& from& glucoseZ6Zphosphate& to&trioses.& When& 1,2Z13C2Zglucose& is& converted& through& glycolysis,& M+0& and& M+2&pyruvate& will& be& formed,& while& conversion& of& glucose& to& pyruvate& through& the&oxidative&pentose&phosphate&pathway&will&lead&to&M+0,&M+1,&and&M+2&pyruvate.&The&
split&ratio&(relative&pathway&activity)&between&glycolysis&and&the&pentose&phosphate&pathway&can&be&estimated&based&on&the&aboveZdescribed&different&labeling&patterns&[72,73].&Notably,&the&difference&in&pyruvate&labeling&is&not&informative&as&to&relative&pentose& phosphate& pathway& and& glycolysis& flux& if& the& nonZoxidative& pentose&phosphate& pathway& flux& is& directed& toward& pentose& production,& as& is& the& case& in&many& cancer& cells& [74,75].& A& more& direct& measurement& of& oxidative& pentose&phosphate&pathway&flux&can&be&obtained&from&quantifying&14CO2&production&from&1Z14C1Zglucose& versus& 6Z14C1Zglucose& [76].& Alternatively,& formal& 13C& flux& analysis& or&isotopomer& analysis& based& on& nuclear& magnetic& resonance& can& be& applied& to&determine&the&oxidative&pentose&phosphate&pathway&activity&from&13CZlabeling&data&(e.g.&[77,78]).&&&Importantly,&if&a&single&nutrient&contributes&to&a&pathway,&then&steady&state&labeling&data& are& not& informative& as& to& relative& or& qualitative& pathway& activity& or& flux.& For&instance,& in&most&cases&glycolytic& intermediates&are&labeled&primarily&from&glucose&and& the& fact& that& glycolytic& intermediates& are& labeled& from&glucose& at& steady& state&does&not&provide&any&information&on&the&magnitude&of&the&glycolytic&flux.&&
Qualitative'changes'in'pathway'contribution&Qualitative& changes& in& pathway& contribution& are& indicative& of& whether& a& certain&pathway&is&used&to&produce&a&metabolite.&Thereby,&only&the&labeling&pattern&that&is&indicative& for& the& pathway& of& interest& is& analyzed.& Consequently,& no& quantitative&split& ratio& is& calculated& between& the& pathway& of& interest& and& the& alternative&conversion& routes,& and& only& qualitative& information& is& obtained.& Examples& are&changes& in& the& fractional&abundance&of&M+5&citrate& from&13C5Zglutamine&to&suggest&reductive& glutamine& metabolism& [79Z84],& or& M+3& malate& from& 13C6Zglucose& to&suggest&contribution&of&pyruvate&via&pyruvate&carboxylase.&The&example&of&pyruvate&carboxylase& is& discussed& in& full& detail& in& Box& 1.& Recognizing& the& limitations& of& the&specific& isotopologues&to&be&indicative&for&relative&pathway&activities&or&qualitative&changes& in&pathway&contribution& is& important,&and&use&of&more& than&one& tracer&as&well&as& investigation&of&more&than&one&metabolite& labeling&can&increase&confidence&in&conclusions&(Box&1).&&Key&aspects:&
• Steady& state& labeling& patterns& are& independent& of& metabolite& levels.&Consequently,& multiplying& MDVs& with& metabolite& levels& at& isotopic& steadyZstate& (or& simply& reporting& the& absolute& magnitudes& of& different& labeled&species)& does& not& reliably& provide& information& on& any& metabolic& changes.&More&reliable&information&is&obtained&by&examining&the&steadyZstate&labeling&fractions& themselves& to& infer& relative& or& qualitative& pathway& activities& and&nutrient&contributions.&
• Relative&pathway&activities&and&qualitative&changes&in&pathway&contribution&to& the&production&of&a&metabolite&do&not&allow&conclusions&on&absolute& flux&magnitudes.&
• Steady& state& labeling& patterns& are& informationZrich& for& metabolites& in&pathways&with&more&than&one&source&of&nutrient&contribution&or&alternative&metabolic&routes&for&nutrient&contribution.&
• Steady& state& labeling& patterns& for& linear& pathways& without& alternative&nutrient&contributions&are&not&informative&for&pathway&activity.&
• If& no& formal& split& ratio& of& pathway& contribution& can& be& calculated,& any&pathway&activity&inferred&from&steady&state&labeling&patterns&is&qualitative.&
• It& is& important& to& remember& that& relative& contributions&may& change&due& to&the& increased& activity& of& one& pathway,& or& the& decreased& activity& of& another&pathway.&
• Analysis& of& labeling& patterns& from& more& than& one& 13C& tracer& can& increase&confidence&in&data&interpretation.&
• Analysis& of& labeling& patterns& in& more& than& one& metabolite& can& increase&confidence&in&data&interpretation.&&
Dynamic"labeling"&Dynamic& labeling& is&a&powerful&method& to& infer& flux& from&metabolite& labeling&data&and&metabolite&levels&(Figure&2d)&[30,41,51,85].&During&dynamic&labeling,&how&fast&a&metabolite&pool&becomes& labeled& is&measured.&The&underlying&principle& is& that& the&greater& a& flux& the& faster& a&metabolite&pool& becomes& labeled;& however,& considering&the&size&of&the&metabolite&pool&is&critical&as&larger&metabolite&pools&will&take&longer&to& be& labeled& than& smaller& metabolite& pools& (Figure& 2d).& Thus,& dynamic& labeling&patterns&are&inherently&metabolite&level&dependent,&and&will&also&depend&on&the&pool&size& and& labeling& rates& of& upstream&metabolites& if& the& labeled& intermediate& is& not&directly&produced&from&the&13C&tracer.&&Integrating&dynamic&labeling&data&into&metabolic&models&has&mainly&been&applied&to&microbial&systems,&although&other&systems&have&been&recently& investigated&as&well&[34,39,86Z89].&For&a&meaningful&direct&interpretation&of&dynamic&labeling&patterns&a&suitable&time&resolution&(i.e.&multiple&time&points&that&cover&the&labeling&dynamics)&and&measurement&of&the&metabolites&that&are&upstream&of&the&metabolite&of&interest&are&essential.&This&is&required&to&a)&obtain&reliable&curve&fits&and&b)&determine&when&the&dynamic&profile&transitions&to&steady&state&labeling.&Notably,&dynamic&labeling&is&limited& by& the& feasible& time& resolution.& Therefore,& low& flux& pathways& such& as&glutamine&anaplerosis&to&the&TCA&cycle&(conversion&of&glutamine&to&αZketoglutarate)&are&easier&to&correctly&infer&with&dynamic&labeling&data&than&high&flux&pathways&such&as& glycolysis.& Additionally,& the& direct& interpretation& of& dynamic& labeling& patterns&(without& sophisticated&methods& such& as& nonZstationary& 13C& flux& analysis)& requires&that&the&metabolite&levels&are&constant&over&time.&In&practice,&this&is&often&achieved&by& exchanging& the&medium& for& a& period& of& time& with& unlabeled&medium& prior& to&adding&13CZlabeled&media.&This&allows&the&intracellular&metabolite&levels&that&are&in&rapid&exchange&with& the&medium&(e.g.& lactate)& to&equilibrate& to&a&medium&without&high& levels& of& these& metabolites& present& extracellularly.& Importantly,& 13C& tracer&analysis& as& discussed& here& is& only& valid& if& the& media& change& does& not& affect& the&metabolic&steady&state.&
&For&calculating&fluxes&from&dynamic&labeling&data&two&cases&have&to&be&considered.&Either&the&direct&substrate&metabolite&of&the&reaction&of&interest&is&100%&labeled&and&the&metabolite&of& interest& is&not&a&product& from&a&condensation&reaction,&or& this& is&not&the&case.&In&the&first&case&flux&can&be&calculated&based&on&equation&(4)&[51].&&&!!!!" = !−!! ! ∙ !(!!!!)& (4)&&Here,& XU& is& the& unlabeled& metabolite& level,& fX& is& the& sum& of& fluxes& producing& the&metabolite&X&from&the&tracer&substrate&and&XT&is&the&total&metabolite&level&(sum&of&all&labeling&states).&Hence,&XU/'XT&is&the&fraction&of&M+0&in&the&metabolite&of&interest.&In&the& second& case& isotopically& nonZstationary& 13C& flux& analysis& [30,40,85]& or& kinetic&flux& profiling& [51,90,91]& can& be& performed.& These& methods& require& the& same&additional& data& and& information& as& steady& state& 13C& flux& analysis& and/or&measurements& of& metabolite& levels& along& the& pathway& of& interest.& Moreover,& to&measure& biosynthesis& and& turnover& of& polymers& mass& isotopomer& distribution&analysis&(MIDA)&[92]&or&isotopomer&spectral&analysis&(ISA)&[93]&can&be&applied.&&In& some& experimental& setups,& pragmatic& simplifications& to& compare& flux& between&two&conditions&have&been&applied&[66,94,95].&For&example,&a&pulse&of&a&fully&labeled&carbon&source&is&added&to&the&medium&in&a&reference&and&in&a&perturbed&condition&(e.g.&mutant,&or&drug& treatment).&Under& the&precondition& that&all&metabolite& levels&along& the& pathway& of& interest& are& lower& in& the& perturbed& condition& than& in& the&reference&condition,&a&slower&or&equal&decrease&in&M+0&of&the&metabolite&of&interest&in&the&perturbed&condition&signifies&a&lower&pathway&flux&in&the&perturbed&condition&(Figure&2e).&To&allow&assessment&of&metabolite& levels&and& labeling&dynamics,&both&parameters& should& be& depicted& separately.& Notably,& such& a& qualitative& analysis& of&dynamic&labeling&data&and&metabolite&levels&are&subject&to&the&assumption&that&the&nonZcompartment&specific&metabolite& level&measurement&does&not& impact&the&data&interpretation&and&that& the&metabolites&of& the&pathway&of& interest&are&not& in&rapid&exchange& with& other& metabolites& outside& the& pathway.& If& doubts& about& these&assumptions& exist,& then& conclusions& based& on& the& assumptions& should& be& verified&with&formal&nonZstationary&13C&flux&analysis.&&Key&aspects:&
• Multiple& time&points&are&essential& to& interpret&directly&dynamic& 13C& labeling&patterns.& Interpretations& of& single& time& points& of& dynamic& 13C& labeling&patterns&are&not&reliable.&
• Dynamic& labeling& is& limited& by& the& feasible& time& resolution& (e.g.& glycolytic&intermediates&are&labeled&in&the&second&to&minute&range).&&
• Qualitative& and& quantitative& assessment& of& dynamic& labeling& patterns&(without&formal&nonZstationary&13C&flux&analysis)&must&take&metabolite&levels&into&account.&
• Interpretation&of&labeling&dynamics&in&a&pathway&with&metabolites&that&are&in&rapid& exchange& with& other& metabolites& outside& a& pathway& require& other&approaches&than&the&here&discussed&direct&13C&tracer&analysis.&
• CompartmentZdependent& metabolite& production& can& impact& the&interpretation&of&dynamic&labeling&data.&&
Concluding"remarks"&13CZ& and& other& isotopeZlabeled& tracers& can& be& powerful& tools& to& interrogate& the&metabolism& of& cells.& They& can& determine& relative& pathway& activities,& qualitative&changes& in& pathway& contribution,& nutrient& contributions,& and&help& infer&metabolic&fluxes.&Analysis&using&more&than&one&tracer&and&examination&of&multiple&metabolites&can&help& to& increase& the& confidence& in& conclusions& from&direct& 13C& tracer& analysis.&Moreover,& integration&of& labeling&data&with& additional& information& such& as& uptake&and&secretion&rates&will&increase&the&resulting&understanding&of&cellular&metabolism&and&confidence&in&the&biological&conclusions.&Importantly,&the&biological&question&of&interest& dictates& which& metabolic& parameters& (uptake& rates,& relative& pathway&activities,& pathway/nutrient& contributions,& or& fluxes)& are& most& important& to&determine.&Taking&into&account&the&considerations&discussed&here&will&hopefully&be&useful&to&the&growing&set&of&scientists&engaged&in&metabolic&tracer&studies.&&
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Figure"Legends"&Figure& 1:& Labeling& basics.& a)& Time& dependent& metabolic& changes:& metabolism&reaches& a& metabolic& steady& state& when& the& parameters& of& interest& (e.g.& glucose&uptake& rate)& are& constant& over& time.& b)& Time& dependent& labeling& changes:& upon&addition& of& an& isotopically& labeled& carbon& source,& the& isotopic& enrichment& will&increase& in& the&metabolites& until& the& steady& state& enrichment& is& reached.& c)&Mass&distribution& vector& (MDV)& (also& known& as& mass& isotopomer& distribution& (MID)&vector):&Labeling&patterns&are&MDVs&that&consist&of&the&fractional&abundance&of&each&isotopologue& (mass& isotopomer).& M& denotes&mass& of& the& unlabeled&metabolite.& d)&Cellular& compartmentalization:& Most& labeling& pattern& detection& methods& cannot&
resolve&different&cellular&compartments,&thus&the&whole&cell&average&labeling&pattern&is&measured.&&Figure& 2:& Interpretation& of& labeling& data.& a)& Steady& state& labeling& data& are&independent& from& the& metabolite& levels.& b)& Fractional& contribution& quantifies& the&contribution&of&a& labeled&nutrient& to& the&metabolite&of& interest.& c)&Exchange& fluxes&can& lead&to&rapidly& labeled&metabolites&although&the&net& flux&of& the&nutrient& to& the&metabolites& is&small.&d)&Dynamic& labeling&patterns&are&metabolite& level&dependent:&The& flux& from& glutamine& to& glutamate& is& the& same& in& condition& A& and& B,& but& in&condition&A&the&glutamate&levels&are&greater&than&in&condition&B.&Consequently,&the&labeling& dynamics& of& glutamate& in& condition& A& are& slower& than& in& condition& B&although& the& flux& from& glutamine& to& glutamate& is& the& same& in& both& conditions.& e)&Relative&flux&activity&between&two&conditions&can&be&evaluated&without&kinetic&flux&calculations&if&both&the&labeling&dynamics&and&all&metabolite&levels&of&the&pathway&of&interest&are&altered&in&the&same&direction.&&Box&1:&Qualitative& changes& in&pathway&contribution:& 13C& tracer&analysis& to& identify&changes&in&pyruvate&anaplerosis.&&
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c) mass distribution vector (MDV)
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labeling patterns due to symmetry in 
fumarate / succinate are not depicted
Pyruvate anaplerosis is the counterpart to glutamine anaplerosis and allows the TCA cycle to continuously oxidize acetyl-CoA simultaneously to providing carbon 
backbones for biomass production. During pyruvate anaplerosis, pyruvate is converted via pyruvate carboxylase to oxaloacetate to compensate for metabolite loss 
from TCA cycle due to biomass production.
Pyruvate anaplerosis can be identified by measuring M+3 malate, oxaloacetate, or fumarate under conditions when 13C6-glucose is consumed (a). Notably, 
oxaloacetate is not measurable by many metabolomics protocols because it requires a direct derivatization during quenching due to its chemical instability [96]. 
However, the labeling pattern of aspartate can serve as a surrogate of oxaloacetate labeling in aspartate-free medium, because if the medium does not contain 
this amino acid, oxaloacetate is the sole source of aspartate carbon. Notably, if oxaloacetate from pyruvate anaplerosis is further used in the TCA cycle, also a 
fraction of M+5 citrate from 13C6-glucose will appear, because M+3 oxaloacetate will be combined with M+2 acetyl-CoA.
Under 13C6-glucose labeling conditions M+3 malate, aspartate, and fumarate can also be formed by multiple oxidation rounds in the TCA cycle (b). Hence, to 
ensure that the M+3 malate, aspartate, and fumarate from 13C6-glucose are indicative of pyruvate anaplerosis, this isotopologue should be compared to the M+3 
succinate (b). Comparison between malate, aspartate, and fumarate with succinate is thereby directly possible because they all consist of the same four-carbon 
backbone. Thus, differences between the M+3 in malate, aspartate, and fumarate and the M+3 succinate represents the pyruvate anaplerosis contribution to the 
TCA cycle, given that fumarate reductase activity is absent. 
Fumarate reductase activity of the succinate dehydrogenase complex converts fumarate to succinate and thereby constitutes anaerobic electron transport. This 
activity is found in many bacteria and fungi, but it has been also shown to occur in some mammalian cells during starvation, ischemic, or hypoxic conditions [97-
99]. When fumarate reductase activity is observed under 13C6-glucose labeling conditions, the M+3 malate, aspartate, and fumarate can match the M+3 succinate 
although pyruvate anaplerosis is active (c). Therefore, the M+3 malate, aspartate, and fumarate should also be compared to the M+3 and M+4 a-ketoglutarate, 
because the a-ketoglutarate to succinate reaction can be considered to operate only in forward direction (c). Notably, a-ketoglutarate consists of a five carbon 
backbone and in the reaction to succinate CO2  is lost. Thus, this difference in the carbon backbone has to be taken into account when the MDVs of malate, 
aspartate, and fumarate are compared to a-ketoglutarate.
To quantify the contribution of pyruvate to TCA cycle via pyruvate carboxylase more precisely, 1-13C1-pyruvate (or 3,4-
13C2-glucose, which is converted to 1-
13C1-
pyruvate) can be used (d)  [100,101]. Using these tracers, the 13C labeled carbon is lost in the pyruvate dehydrogenase reaction but is retained when pyruvate 
enters via pyruvate anaplerosis into the TCA cycle (d). Notably, when using a pyruvate tracer in the presence of glucose as a carbon source, the enrichment of 13C-
pyruvate needs to be taken into account when estimating relative pyruvate anaplerosis. 
c) exchange flux versus net flux
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Pyruvate anaplerosis is the counterpart to glutamine anaplerosis and allows the TCA cycle to continuously oxidize acetyl-CoA simultaneously to providing carbon 
backbones for biomass production. During pyruvate anaplerosis, pyruvate is converted via pyruvate carboxylase to oxaloacetate to compensate for metabolite loss 
from TCA cycle due to biomass production.
Pyruvate anaplerosis can be identified by measuring M+3 malate, oxaloacetate, or fumarate under conditions when 13C6-glucose is consumed (a). Notably, 
oxaloacetate is not measurable by many metabolomics protocols because it requires a direct derivatization during quenching due to its chemical instability [96]. 
However, the labeling pattern of aspartate can serve as a surrogate of oxaloacetate labeling in aspartate-free medium, because if the medium does not contain 
this amino acid, oxaloacetate is the sole source of aspartate carbon. Notably, if oxaloacetate from pyruvate anaplerosis is further used in the TCA cycle, also a 
fraction of M+5 citrate from 13C6-glucose will appear, because M+3 oxaloacetate will be combined with M+2 acetyl-CoA.
Under 13C6-glucose labeling conditions M+3 malate, aspartate, and fumarate can also be formed by multiple oxidation rounds in the TCA cycle (b). Hence, to 
ensure that the M+3 malate, aspartate, and fumarate from 13C6-glucose are indicative of pyruvate anaplerosis, this isotopologue should be compared to the M+3 
succinate (b). Comparison between malate, aspartate, and fumarate with succinate is thereby directly possible because they all consist of the same four-carbon 
backbone. Thus, differences between the M+3 in malate, aspartate, and fumarate and the M+3 succinate represents the pyruvate anaplerosis contribution to the 
TCA cycle, given that fumarate reductase activity is absent. 
Fumarate reductase activity of the succinate dehydrogenase complex converts fumarate to succinate and thereby constitutes anaerobic electron transport. This 
activity is found in many bacteria and fungi, but it has been also shown to occur in some mammalian cells during starvation, ischemic, or hypoxic conditions [97-
99]. When fumarate reductase activity is observed under 13C6-glucose labeling conditions, the M+3 malate, aspartate, and fumarate can match the M+3 succinate 
although pyruvate anaplerosis is active (c). Therefore, the M+3 malate, aspartate, and fumarate should also be compared to the M+3 and M+4 a-ketoglutarate, 
because the a-ketoglutarate to succinate reaction can be considered to operate only in forward direction (c). Notably, a-ketoglutarate consists of a five carbon 
backbone and in the reaction to succinate CO2  is lost. Thus, this difference in the carbon backbone has to be taken into account when the MDVs of malate, 
aspartate, and fumarate are compared to a-ketoglutarate.
To quantify the contribution of pyruvate to TCA cycle via pyruvate carboxylase more precisely, 1-13C1-pyruvate (or 3,4-
13C2-glucose, which is converted to 1-
13C1-
pyruvate) can be used (d)  [100,101]. Using these tracers, the 13C labeled carbon is lost in the pyruvate dehydrogenase reaction but is retained when pyruvate 
enters via pyruvate anaplerosis into the TCA cycle (d). Notably, when using a pyruvate tracer in the presence of glucose as a carbon source, the enrichment of 13C-
pyruvate needs to be taken into account when estimating relative pyruvate anaplerosis. 
c) exchange flux versus net flux
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total ion count (TIC)
S = 88000
MDV (IC/TIC)
M+3    40500         0.46
a) metabolic changes b) labeling changes
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c) mass distribution vector (MDV)
labeling patterns due to symmetry in fumarate / 
succinate and glutamine anaplerosis are not depicted
labeling patterns due to symmetry in fumarate / 
succinate and glutamine anaplerosis are not depicted
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labeling patterns due to symmetry in 
fumarate / succinate are not depicted
Pyruvate anaplerosis is the counterpart to glutamine anaplerosis and allows the TCA cycle to continuously oxidize acetyl-CoA simultaneously to providing carbon 
backbones for biomass production. During pyruvate anaplerosis, pyruvate is converted via pyruvate carboxylase to oxaloacetate to compensate for metabolite loss 
from TCA cycle due to biomass production.
Pyruvate anaplerosis can be identified by measuring M+3 malate, oxaloacetate, or fumarate under conditions when 13C6-glucose is consumed (a). Notably, 
oxaloacetate is not measurable by many metabolomics protocols because it requires a direct derivatization during quenching due to its chemical instability [96]. 
However, the labeling pattern of aspartate can serve as a surrogate of oxaloacetate labeling in aspartate-free medium, because if the medium does not contain 
this amino acid, oxaloacetate is the sole source of aspartate carbon. Notably, if oxaloacetate from pyruvate anaplerosis is further used in the TCA cycle, also a 
fraction of M+5 citrate from 13C6-glucose will appear, because M+3 oxaloacetate will be combined with M+2 acetyl-CoA.
Under 13C6-glucose labeling conditions M+3 malate, aspartate, and fumarate can also be formed by multiple oxidation rounds in the TCA cycle (b). Hence, to 
ensure that the M+3 malate, aspartate, and fumarate from 13C6-glucose are indicative of pyruvate anaplerosis, this isotopologue should be compared to the M+3 
succinate (b). Comparison between malate, aspartate, and fumarate with succinate is thereby directly possible because they all consist of the same four-carbon 
backbone. Thus, differences between the M+3 in malate, aspartate, and fumarate and the M+3 succinate represents the pyruvate anaplerosis contribution to the 
TCA cycle, given that fumarate reductase activity is absent. 
Fumarate reductase activity of the succinate dehydrogenase complex converts fumarate to succinate and thereby constitutes anaerobic electron transport. This 
activity is found in many bacteria and fungi, but it has been also shown to occur in some mammalian cells during starvation, ischemic, or hypoxic conditions [97-
99]. When fumarate reductase activity is observed under 13C6-glucose labeling conditions, the M+3 malate, aspartate, and fumarate can match the M+3 succinate 
although pyruvate anaplerosis is active (c). Therefore, the M+3 malate, aspartate, and fumarate should also be compared to the M+3 and M+4 a-ketoglutarate, 
because the a-ketoglutarate to succinate reaction can be considered to operate only in forward direction (c). Notably, a-ketoglutarate consists of a five carbon 
backbone and in the reaction to succinate CO2  is lost. Thus, this difference in the carbon backbone has to be taken into account when the MDVs of malate, 
aspartate, and fumarate are compared to a-ketoglutarate.
To assess the contribution of pyruvate to TCA cycle via pyruvate carboxylase with an additional tracer, 1-13C1-pyruvate (or 3,4-
13C2-glucose, which is converted to 
1-13C1-pyruvate) can be used (d)  [100,101]. Using these tracers, the 
13C labeled carbon is lost in the pyruvate dehydrogenase reaction but is retained when 
pyruvate enters via pyruvate anaplerosis into the TCA cycle (d). Any further TCA cycle metabolization of oxaloacetate from pyruvate anaplerosis, however, will lead 
to loss of the the labeled carbon (d). Notably, when using a pyruvate tracer in the presence of glucose as a carbon source, the enrichment of 13C-pyruvate needs to 
be taken into account when estimating relative pyruvate anaplerosis.
Hence, pyruvate anaplerosis is a good example that it can be helpful to depict not only the isotopologue of interest, but the MDVs of multiple connected 
metabolites. 
c) exchange flux versus net flux
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